WHY DO WE WANT TO ESTABLISH HATCH
Autism Spectrum Disorder (ASD) and eczema are two common conditions that affect 85 million children globally. While the annual medical costs is over 300 billion USD in the U.S., the negative social and psychological impacts of these conditions on the affected children and families are beyond imagination. It is known that gut bacteria (microbiota) play a vital role in many conditions such as colon cancer, obesity, diabetes, depression, dementia, eczema, and ASD.
By mapping individual profiles of good and bad bacteria, novel diagnostic biomarkers for early detection can be identified and personalized microbial replacement therapy would be offered to prevent or ameliorate many conditions not only limited to ASD and eczema. Modulation of children’s gut microbiota offers new hope to prevent onset of diseases and improves treatment outcomes.
In the near future, prediction of ASD before its onset using our novel stool microbial markers become possible so we establish the Hub of Advanced Technology for Child Health (HATCH) that specifically focus on ASD and eczema. In addition, we anticipate that HATCH will fulfil the unmet needs of important childhood conditions that are not supported by existing funding.
With our innovations in microbial diagnostics and replacement therapies, our mission is to bring health and hope to our future generation through research, education, and community outreach.
Generating patent-protected innovations that can be turned into services or products to enhance early detection and improve treatment outcomes of autism and eczema.
Nurturing young researchers and entrepreneurs.
Building a cross disciplinary platform to create synergy with different Institutes of The D. H. Chen Foundation to enhance community outreach.
Growth Partner and Funder
THE D. H. CHEN
Promoting wellbeing in our community is one of the commitments at The D. H. Chen Foundation. From our next generations to older adults, we take care of their wellbeing both physically and socioemotionally through community engagement and education in partnerships of like-minded change makers.
A Hong Kong family philanthropic trust established in 1970 by the founder of the Nan Fung Group Dr. Din Hwa Chen, The D. H. Chen Foundation has been putting compassion into action through steering and supporting innovative, impactful and sustainable community initiatives to realize Dr. Chen's philosophy - "Care for others as well as you would care for yourself". Join us to build a compassionate society together.
With top-notch researchers from The Chinese University of Hong Kong (CUHK), University of Chicago, The University of Melbourne and University of Cambridge, the newly founded Microbiota I-Center (MagIC) focuses on advancing science in the gut microbiome and promoting entrepreneurship. It is committed to developing a novel class of microbiome diagnostics and live biotherapeutics for common diseases including obesity, cancer, ASD, inflammatory disorders and COVID-19, that will not only transform lives of patients and their families, but also accelerate Hong Kong into a world-class microbiome biotechnology hub.
Prof. Tai-Fai Fok
Emeritus Professor & Honorary Clinical Professor, Department of Paediatrics, CUHK
Ms. Karen Cheung
Trustee & Chief Strategist,
The D. H. Chen Foundation
Prof. Francis Chan
Dean, Faculty of Medicine, CUHK
Microbiota I-Center (MagIC)
Prof. Siew Ng
Assistant Dean (Development), CUHK
Professor, Department of Medicine and Therapeutics, Faculty of Medicine, CUHK
Microbiota I-Center (MagIC)